NO20005628D0 - Fremgangsmåte for utvelgelse av et virus - Google Patents

Fremgangsmåte for utvelgelse av et virus

Info

Publication number
NO20005628D0
NO20005628D0 NO20005628A NO20005628A NO20005628D0 NO 20005628 D0 NO20005628 D0 NO 20005628D0 NO 20005628 A NO20005628 A NO 20005628A NO 20005628 A NO20005628 A NO 20005628A NO 20005628 D0 NO20005628 D0 NO 20005628D0
Authority
NO
Norway
Prior art keywords
virus
polypeptide
fusion
selecting
propagating
Prior art date
Application number
NO20005628A
Other languages
English (en)
Other versions
NO329172B1 (no
NO20005628L (no
Inventor
Lutz Riechmann
Peter Kristensen
Jean-Luc Jestin
Gregory Paul Winter
Original Assignee
Diversys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810228.8A external-priority patent/GB9810228D0/en
Priority claimed from GBGB9810223.9A external-priority patent/GB9810223D0/en
Application filed by Diversys Ltd filed Critical Diversys Ltd
Publication of NO20005628D0 publication Critical patent/NO20005628D0/no
Publication of NO20005628L publication Critical patent/NO20005628L/no
Publication of NO329172B1 publication Critical patent/NO329172B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Vehicle Body Suspensions (AREA)
  • Circuits Of Receivers In General (AREA)
  • Air Bags (AREA)
NO20005628A 1998-05-13 2000-11-08 Fremgangsmate for seleksjon av et korrekt foldet fusjonspolypeptid NO329172B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9810228.8A GB9810228D0 (en) 1998-05-13 1998-05-13 Selection method
GBGB9810223.9A GB9810223D0 (en) 1998-05-13 1998-05-13 Selection system
PCT/GB1999/001526 WO1999058655A2 (en) 1998-05-13 1999-05-13 Phage display selection system for folded proteins

Publications (3)

Publication Number Publication Date
NO20005628D0 true NO20005628D0 (no) 2000-11-08
NO20005628L NO20005628L (no) 2001-01-12
NO329172B1 NO329172B1 (no) 2010-09-06

Family

ID=26313668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005628A NO329172B1 (no) 1998-05-13 2000-11-08 Fremgangsmate for seleksjon av et korrekt foldet fusjonspolypeptid

Country Status (14)

Country Link
US (2) US7442159B1 (no)
EP (2) EP1078051B1 (no)
JP (2) JP4493846B2 (no)
AT (1) ATE380865T1 (no)
AU (1) AU762814B2 (no)
CA (1) CA2328422A1 (no)
CY (1) CY1107293T1 (no)
DE (1) DE69937735T2 (no)
DK (1) DK1078051T3 (no)
ES (1) ES2299244T3 (no)
GB (1) GB2361237A (no)
NO (1) NO329172B1 (no)
PT (1) PT1078051E (no)
WO (1) WO1999058655A2 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5122499A (en) 1998-07-27 2000-02-21 Genentech Inc. Improved transformation efficiency in phage display through modification of a coat protein
IL142025A0 (en) 1999-07-20 2002-03-10 Morphosys Ag Novel methods for displaying (poly) peptides/proteins on bacteriophage particles via disulfide bonds
JP2003523742A (ja) * 2000-02-03 2003-08-12 ドマンティス リミテッド コンビナトリアルタンパク質ドメイン
GB0019049D0 (en) * 2000-08-04 2000-09-27 Neutec Pharma Plc Combinatorial chemistry method
AU2001277614A1 (en) * 2000-08-07 2002-02-18 Domantis Limited Novel proteins
DE10135039C1 (de) * 2001-07-18 2003-03-13 Nemod Immuntherapie Ag Verfahren zur Isolierung großer Varianzen spezifischer Moleküle für ein Zielmolekül aus Phagemid-Gen-Bibliotheken
EP2357237A1 (en) 2003-05-14 2011-08-17 Domantis Limited A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
RU2412249C2 (ru) 2005-07-08 2011-02-20 Юниверсити Оф Цюрих Фаговый дисплей с применением котрансляционной транслокации слитых полипептидов
GB2428293A (en) * 2005-07-13 2007-01-24 Domantis Ltd Phage display libraries
US20090305898A1 (en) * 2005-07-21 2009-12-10 Ilan Morad Methods and Compositions for Identifying a Peptide Having an Intermolecular Interaction With a Target of Interest
GB0515115D0 (en) 2005-07-22 2005-08-31 Isogenica Ltd Peptide characterisation
EP2032701B1 (en) * 2006-06-23 2013-11-27 Alethia Biotherapeutics Inc. Polynucleotides and polypeptides involved in cancer
MX2009013137A (es) 2007-06-06 2010-04-30 Domantis Ltd Metodos para seleccionar polipeptidos resistentes a la proteasa.
DK2190987T3 (da) 2007-08-21 2013-02-18 Morphosys Ag Fremgangsmåder til dannelse af disulfidbindinger
EP2222709B1 (en) 2007-11-30 2016-11-23 Glaxo Group Limited Antigen-binding constructs
AU2009321508B2 (en) 2008-11-03 2015-03-12 Adc Therapeutics Sa Antibodies that specifically block the biological activity of a tumor antigen
CN102307897B (zh) 2008-12-05 2016-01-20 葛兰素集团有限公司 选出蛋白酶抗性多肽的方法
CA2753287A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
CA2753332A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
CA2753263A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Multivalent and/or multispecific rankl-binding constructs
WO2012069557A1 (en) 2010-11-24 2012-05-31 Glaxo Group Limited Multispecific antigen binding proteins targeting hgf
CN103492418B (zh) 2011-03-31 2016-06-29 阿莱斯亚生物疗法股份有限公司 针对肾相关抗原1的抗体及其抗原结合片段
KR101632620B1 (ko) 2011-07-27 2016-06-23 글락소 그룹 리미티드 Ｆｃ 도메인에 융합된 항­ｖｅｇｆ 단일 가변 도메인
EP3431589A1 (en) * 2011-10-27 2019-01-23 The Governors of the University of Alberta Device and method for bacterial culture and assay
BR112014016723A2 (pt) 2012-01-09 2018-07-24 Alethia Biotherapeutics Inc. método para o tratamento de câncer de mama
AU2014324884B2 (en) * 2013-09-25 2020-03-26 Cytomx Therapeutics, Inc Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
DK3628328T3 (da) 2014-01-31 2022-12-05 Cytomx Therapeutics Inc Matriptase- og u-plasminogen-aktivatorsubstrater og andre spaltelige dele og fremgangsmåder til anvendelse deraf
US20180340174A1 (en) * 2014-11-11 2018-11-29 Nanocore Aps Method for identification of molecules with desired characteristics
MA41374A (fr) 2015-01-20 2017-11-28 Cytomx Therapeutics Inc Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
CN107427577A (zh) * 2015-03-31 2017-12-01 韦斯夸尔德有限公司 具有蛋白酶可切割接头的肽构建体
US20220228172A1 (en) * 2019-06-21 2022-07-21 Boehringer Ingelheim International Gmbh Novel Mechanism to Control RNA Virus Replication and Gene Expression

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
AU634186B2 (en) 1988-11-11 1993-02-18 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
CA2109602C (en) * 1990-07-10 2002-10-01 Gregory P. Winter Methods for producing members of specific binding pairs
JP4146512B2 (ja) * 1991-03-01 2008-09-10 ダイアックス コープ． 小型タンパク質
DE4122599C2 (de) * 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
DE69233782D1 (de) 1991-12-02 2010-05-20 Medical Res Council Herstellung von Autoantikörpern auf Phagenoberflächen ausgehend von Antikörpersegmentbibliotheken

Also Published As

Publication number Publication date
DE69937735D1 (de) 2008-01-24
EP1950295A1 (en) 2008-07-30
NO329172B1 (no) 2010-09-06
PT1078051E (pt) 2008-03-17
ES2299244T3 (es) 2008-05-16
WO1999058655A3 (en) 2000-01-27
US20090203542A1 (en) 2009-08-13
JP2002514413A (ja) 2002-05-21
EP1078051B1 (en) 2007-12-12
JP2010148507A (ja) 2010-07-08
ATE380865T1 (de) 2007-12-15
GB0026143D0 (en) 2000-12-13
AU3941399A (en) 1999-11-29
JP5161865B2 (ja) 2013-03-13
CA2328422A1 (en) 1999-11-18
DK1078051T3 (da) 2008-04-07
EP1078051A2 (en) 2001-02-28
US8680018B2 (en) 2014-03-25
WO1999058655A2 (en) 1999-11-18
JP4493846B2 (ja) 2010-06-30
CY1107293T1 (el) 2012-11-21
NO20005628L (no) 2001-01-12
GB2361237A (en) 2001-10-17
DE69937735T2 (de) 2008-11-27
US7442159B1 (en) 2008-10-28
AU762814B2 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
NO20005628D0 (no) Fremgangsmåte for utvelgelse av et virus
ATE198491T1 (de) System zur expression von heterologen antigenen als fusionsproteine
BR9810654B8 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
DK2025753T3 (da) Fagmid til screening af antistoffer
ID24490A (id) Metode untuk menggunakan dan metode pembuatan tabung oven-pijar
ATE339507T1 (de) Erythropoietin-analog-menschliches serum-albumin fusionsprotein
HK1038244A1 (en) A method for the high level expression of the active form of lymphotoxin- beta receptor immunoglobulin fusion proteins and their purification
DE69633563D1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
NO20002504L (no) Adenovirusvektorer og fremgangsmÕte for Õ redusere homologe rekombinasjonsfenomener
DK0977873T3 (da) Fremgangsmåde til spaltning af fusionsproteiner
IS6678A (is) Hvarfefni og prófanir fyrir ß-sekretasavirkni
WO2002022662A3 (en) Insect inhibitory bacillus thuringiensis proteins, fusions, and methods of use therefor
NO20052552D0 (no) Loselige Notch-baserte substrater for gamma-sekretase og fremgangsmater og blandinger for anvendelse av samme.
ID24590A (id) Metode dan komposisi untuk pembuatan lensa oftalmil berwarna
WO2000031127A3 (en) Protein fragments for use in protein targeting
DE69534178D1 (en) S?ugetier thymokingene
DE69611896D1 (de) Fusions-DNS-Sequenz, dadurch exprimiertes Fusionsprotein und Verfahren zur Expression dieses Fusionsproteins
DK0829579T3 (da) Farbart bindelag og fremgangsmåde til den fremstilling
WO2000034335A3 (en) 'death domain' containing receptors
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
AR016145A1 (es) Citoquinas de mamifero; reactivos relacionados
DK0786476T3 (da) Sammensætning og fremgangsmåde til limning af plane strukturer
US5807733A (en) Mammalian prostaglandin H synthase-2 fusion proteins
DE59105878D1 (de) VERFAHREN ZUR ENZYMATISCHEN SPALTUNG REKOMBINANTER PROTEINE UNTER VERWENDUNG VON IgA-PROTEASEN.

Legal Events

Date Code Title Description
MK1K Patent expired